If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 1 - 4 of 4
Parkinson's Foundation PD GENEration Genetic Registry
Objective
Parkinson's Foundation PD GENEration Genetic Registry
Protocol No
NEURO-PF-PDGENE
A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera system in Subjects with Upper Extremity Spasticity
Objective
Iovera in Upper Extremity Spasticity
Protocol No
PMR-PACIRA-IOV-301
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinson's Disease (NEULARK)
Objective
NEU-411 in Companion Diagnostic-Positive Participants with Early Parkinsons Disease
Protocol No
NEURO-NEURON23-NEULARK
An Open-Label Clinical Trial Investigating the Long-Term Safety of Buntanetap in Treating Participants with Parkinson's Disease
Objective
Long-Term Safety of Buntanetap in Parkinson's Disease
Protocol No
NEURO-ANNOVIS-ANVS-25002